Dutch Life Science Database

News in the Life Sciences Industry
Results 101 - 120 out of 221 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 »

Sanofi successfully prices taps on outstanding bond issues for EUR 500 million

By: GlobenewsWire - 06 Apr 2020

Qu Biologics publishes landmark studies showing cells of the innate immune system can be directed to target organ sites to prevent and clear pathology and infection

By: GlobenewsWire - 06 Apr 2020

Rybelsus® (oral semaglutide) approved for the treatment of adults with type 2 diabetes in the EU

By: GlobenewsWire - 04 Apr 2020

Sanofi: Availability of the Pre-quarterly Results Communication

By: GlobenewsWire - 03 Apr 2020

Sanofi: Dupixent® (dupilumab) Phase 3 data show significant improvement in severe atopic dermatitis for children aged 6 to 11 years

By: GlobenewsWire - 03 Apr 2020

Univar Solutions Partners with INEOS to Combat the Hand Sanitizer Shortage in Europe

ROTTERDAM, Netherlands, April 1, 2020 /PRNewswire/ -- Europe, Univar B.V., a subsidiary of Univar Solutions Inc. (NYSE: UNVR) ("Univar Solutions" or "The Company"), a global chemical and ingredient distributor and provider of value-added services, announced today it has joined forces with INEOS... Read more ››

By: PR Newswire Association LLC. - 01 Apr 2020

MDxHealth Updates 2020 Reporting Calendar and Provides Initial View on Coronavirus Situation

By: GlobenewsWire - 01 Apr 2020

Related companies: MDxHealth, Inc. | MDxHealth B.V. | MDxHealth S.A.

Sanofi: Information on Sanofi’s Shareholder General Meeting of Tuesday, April 28, 2020

By: GlobenewsWire - 01 Apr 2020

ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business Update

By: GlobenewsWire - 31 Mar 2020

Related companies: ProQR Therapeutics NV

GHIT Fund Announces New Investments: A Total of 3.29 Billion Yen in Drugs for Malaria, Tuberculosis, Chagas Disease, Lymphatic Filariasis, and Onchocerciasis, Vaccines for Malaria, and Diagnostics for Leishmaniasis and Mycetoma

TOKYO, March 30, 2020 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of 3.29 billion yen (US$30 million*) to invest in 11 partnerships to develop new lifesaving drugs, vaccines and diagnostics for malaria, tuberculosis, Chagas disease, leishmaniasis,... Read more ››

By: PR Newswire Association LLC. - 31 Mar 2020

Novo Nordisk A/S - Share repurchase programme

By: GlobenewsWire - 30 Mar 2020

Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19

By: GlobenewsWire - 30 Mar 2020

CHMP Adopts Positive Opinion for Treatment of Acute Angioedema Attacks in Children With Hereditary Angioedema With RUCONEST®

LEIDEN, Netherlands, March 27, 2020 /PRNewswire/ -- Pharming announces the Committee for Medicinal Products for Human Use (CHMP), an advisory committee of the European Medicine Agency (EMA), has adopted a positive opinion recommending an extension of the indication for RUCONEST® to the European... Read more ››

By: PR Newswire Association LLC. - 27 Mar 2020

Related companies: Pharming Group NV

UCB SA/NV : Convening notice to the general meeting of shareholders

By: GlobenewsWire - 27 Mar 2020

Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19

By: GlobenewsWire - 27 Mar 2020

Sanofi receives positive CHMP opinion for Sarclisa® (isatuximab) for the treatment of relapsed and refractory multiple myeloma

By: GlobenewsWire - 27 Mar 2020

Related companies: ProQR Therapeutics NV

« 1 2 3 4 5 6 7 8 9 10 11 12 »

Looking for companies outside of Netherlands?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

June 2020
- Digital RESI – Three Day Conference
- BIO Digital
- Brussels: The Pharma Business Development Course

See Events »

Add an Event »

Latest company news

Sanofi announces closing of Regeneron stock sale
29 May 2020 (GlobenewsWire)

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time
29 May 2020 (GlobenewsWire)

Kiadis announces new data related to its K-NK cell therapy platform presented today at the ASCO 2020 Virtual Annual Meeting
29 May 2020 (GlobenewsWire)

News in the Life Sciences Industry

Sanofi successfully prices taps on outstanding bond issues for EUR 500 million

Qu Biologics publishes landmark studies showing cells of the innate immune system can be directed to target organ sites to prevent and clear pathology and infection

Rybelsus® (oral semaglutide) approved for the treatment of adults with type 2 diabetes in the EU

Sanofi: Availability of the Pre-quarterly Results Communication

Sanofi: Dupixent® (dupilumab) Phase 3 data show significant improvement in severe atopic dermatitis for children aged 6 to 11 years

Univar Solutions Partners with INEOS to Combat the Hand Sanitizer Shortage in Europe

MDxHealth Updates 2020 Reporting Calendar and Provides Initial View on Coronavirus Situation

Sanofi: Information on Sanofi’s Shareholder General Meeting of Tuesday, April 28, 2020

ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business Update

GHIT Fund Announces New Investments: A Total of 3.29 Billion Yen in Drugs for Malaria, Tuberculosis, Chagas Disease, Lymphatic Filariasis, and Onchocerciasis, Vaccines for Malaria, and Diagnostics for Leishmaniasis and Mycetoma

Novo Nordisk A/S - Share repurchase programme

Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19

CHMP Adopts Positive Opinion for Treatment of Acute Angioedema Attacks in Children With Hereditary Angioedema With RUCONEST®

UCB SA/NV : Convening notice to the general meeting of shareholders

Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19

Sanofi receives positive CHMP opinion for Sarclisa® (isatuximab) for the treatment of relapsed and refractory multiple myeloma

Sanofi: information concerning the total number of voting rights and shares, February 2020

Resolutions from the Annual General Meeting of Novo Nordisk A/S

Novo Nordisk A/S - Articles of Association

ProQR to Present Findings from Phase 1/2 Interim Analysis of QR-421a for Usher Syndrome

Looking for companies outside of Netherlands?

Partners

Upcoming Life Sciences Events

Latest company news